etesevimab

Summary

etesevimab is a monoclonal antibody^[1].

Key Facts

• etesevimab's instance of is recorded as monoclonal antibody^[2].
• etesevimab's instance of is recorded as active ingredient^[3].
• etesevimab's CAS Registry Number is recorded as 2423948-94-9^[4].
• etesevimab's Guide to Pharmacology Ligand ID is recorded as 11331^[5].
• etesevimab's UNII is recorded as N7Q9NLF11I^[6].
• etesevimab's DrugBank ID is recorded as DB15897^[7].
• etesevimab's described by source is recorded as A human neutralizing antibody targets the receptor binding site of SARS-CoV-2^[8].
• etesevimab's described by source is recorded as Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19^[9].
• etesevimab's PubChem Substance ID is recorded as 434321766^[10].
• etesevimab's PubChem Substance ID is recorded as 434370465^[11].
• etesevimab's Google Knowledge Graph ID is recorded as /g/11q_7mlps3^[12].
• etesevimab's RxNorm CUI is recorded as 2477854^[13].
• etesevimab's World Health Organisation international non-proprietary name numeric ID is recorded as 11873^[14].
• etesevimab's legal status is recorded as boxed warning^[15].